Bioprojet Pharma is the first business, created in 1992 for the development and marketing of medicinal products. The secondary business is Bioprojet Biotech, which runs the Group’s R&D and is made up of four units: biochemistry/molecular biology, therapeutic chemistry, pharmacology and pharmacokinetics.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze